This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The main focus of our research is a set of genes called cancer-testis antigens, that are normally expressed exclusively in the human germ line, but which are reactivated in cancer cells. Because of their restricted pattern of expression, CT antigens can be recognized by the immune system and can be potentially used as therapeutic cancer vaccines. The majority of these genes are of unknown function. A major research priority for us is to ascertain the function of CT antigens in both tumors and normal tissues as we believe that they may directly contribute to the establishment and progression of tumors. Identification of binding partners can reveal potential functional roles for these proteins. We intend to use a functional proteomic approach to determine the identity of proteins that interact with several CT antigens.
Showing the most recent 10 out of 583 publications